SUBSCRIBE
SUBSCRIBE

Ikena Oncology

NEWS
Business
BioSpace Movers & Shakers, Aug. 21
Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.
August 20, 2020
 · 
4 min read
 · 
Alex Keown
Job Trends
BioSpace Movers and Shakers: May 10
Pharma and biotech companies strengthen their leadership teams with new hires at Immunocore, Eisai, Kyn, Bicycle, and more.
May 9, 2019
 · 
4 min read
 · 
Alex Keown
$710M Gamble Fails as Celgene Terminates Two Phase
Business
Weeks After $74 Billion Acquisition, Celgene Strikes Two Cancer Deals
Ahead of being absorbed by Bristol-Myers Squibb, Celgene forged a strategic collaboration with two companies to develop immuno-oncology treatments and cell therapies.
January 18, 2019
 · 
3 min read
 · 
Alex Keown
Investor
Genetown
Kyn Therapeutics Banks $49M to Advance Cancer Immunometabolism Therapies
Investors were Atlas Venture and OrbiMed.
December 14, 2017
 · 
2 min read
 · 
Mark Terry
Load More
AWARDS
  • 2023 Best Places to Work
JOBS
IN THE PRESS
Genetown
Ikena Oncology Shares Differentiation Profile of IK-930, a Novel Hippo-Pathway Inhibitor, Including Projected Therapeutic Index Advantages and Breadth of Patient Populations at AACR 2023 Annual Meeting
April 17, 2023
 · 
8 min read
Genetown
Ikena Oncology Presents Preclinical Data on IK-595, Best-in-Class Next-Generation MEK-RAF Complex Inhibitor, in Plenary Session at AACR Special Conference on RAS Targeting
March 7, 2023
 · 
7 min read
Genetown
Ikena Oncology Receives FDA Fast Track Designation for Novel AHR Antagonist IK-175 in Combination with Nivolumab to Treat Urothelial Carcinoma
March 6, 2023
 · 
5 min read
Genetown
Ikena Oncology to Participate in Cowen 43rd Annual Health Care Conference
February 28, 2023
 · 
3 min read
Business
Ikena Oncology Appoints Owen Hughes as Board Chair
December 19, 2022
 · 
5 min read
Genetown
Ikena Oncology Announces New Program in Next-Generation MEK-RAF Inhibition and Provides Corporate Update
November 28, 2022
 · 
7 min read
Genetown
Ikena Oncology to Participate in the Piper Sandler 34th Annual Healthcare Conference
November 22, 2022
 · 
3 min read
Genetown
Ikena Oncology Announces Initial Clinical Data from IK-175 Program in Urothelial Carcinoma
November 10, 2022
 · 
8 min read
Business
UPDATE -- Ikena Oncology Reports Third Quarter 2022 Financial Results and Provides a Corporate Update
November 7, 2022
 · 
10 min read
Business
Ikena Oncology Reports Third Quarter 2022 Financial Results and Provides a Corporate Update
November 7, 2022
 · 
10 min read
Load More